StockWatch
·

Research Reports

31 Jul 2026
AETHERAether Industries Ltd

Aether Q1: consolidated PAT +33% to ₹62.7 Cr on margin expansion, Site 5 onstream

specialty chemicals · margin expansion · capacity commissioning

ResultsQ1 FY273 minMetals & Mining
30 Jul 2026
SIYSILSIYARAM SILK MILLS LTD.-$

Siyaram Q1: revenue +14% YoY tracks guidance; profit up off low base, OPM thins to ~4%

textiles · blended fabrics · apparel retail

ResultsQ1 FY273 minConsumer & Retail
QUICKHEALQuick Heal Technologies Ltd

Quick Heal Q1FY27: revenue -21% YoY, adjusted loss widens; one-off refund flatters PAT

cybersecurity · enterprise expansion · consumer decline

ResultsQ1 FY273 minTechnology / IT
ACIArchean Chemical Industries Ltd

Archean Q1: consolidated PAT falls 24% YoY to ₹30 Cr as bromine pricing squeezes margins

specialty chemicals · bromine · margin compression

ResultsQ1 FY273 minMetals & Mining
MALLCOMMallcom (India) Ltd

Mallcom Q1 FY27: consolidated PAT down 33% YoY as exports slump, margins still recovering

industrial safety products · export slowdown · margin recovery

ResultsQ1 FY273 minIndustrials & Infra
BESTAGROBest Agrolife Ltd

Best Agrolife Q1 turnaround: consolidated PAT doubles to Rs41 Cr as EBITDA margin jumps to 20%

agrochemicals · margin expansion · profit turnaround

ResultsQ1 FY273 minMetals & Mining
AARTIINDAARTI INDUSTRIES LTD.

Aarti Industries Q1: PAT triples to ₹155 Cr on 42% revenue jump, margins expand

specialty chemicals · margin expansion · revenue growth

ResultsQ1 FY273 minMetals & Mining
INDGNIndegene Ltd

Indegene Q1: revenue up 40% YoY but consolidated PAT flat at ₹116 Cr on margin squeeze

life sciences commercialization · pharma outsourcing · healthcare

ResultsQ1 FY273 minPharma & Healthcare
ALIVUSGlenmark Life Sciences Ltd

Alivus Q1 net profit up 32% YoY to ₹160 Cr as margins hit record ~33%

api · pharma · margin expansion

ResultsQ1 FY273 minPharma & Healthcare
NSDLNational Securities Depository Ltd

NSDL Q1: consolidated PAT +10% to ₹98 Cr, margins squeezed as depository profit stays flat

depository · margin compression · payments bank

ResultsQ1 FY273 minFinancial Services
MAZDOCKMazagon Dock Shipbuilders Ltd

Mazagon Dock Q1: consolidated PAT ₹550 Cr, +22% YoY as margins expand, trounces street

defence shipbuilding · margin expansion · profit beat

ResultsQ1 FY273 minIndustrials & Infra
SILVERTUCSilver Touch Technologies Ltd

Silver Touch Q1FY27: consol PAT doubles YoY to ₹10.0 Cr, margins expand sharply

it services · margin expansion · consolidated results

ResultsQ1 FY273 minTechnology / IT
PRICOLLTDPricol Ltd

Pricol Q1: consolidated PAT +34% YoY to ₹67 Cr as revenue climbs 23%, margins widen

auto components · revenue growth · margin expansion

ResultsQ1 FY273 minAutomobile
PRABHAPrabha Energy Ltd

Prabha Energy swings to Q1 profit; revenue up 49% YoY on NK block test sales

oil and gas · exploration production · turnaround

ResultsQ1 FY273 minEnergy & Oil/Gas
DENORADE NORA INDIA LTD.

De Nora India PAT jumps 97% YoY to ₹6.39 Cr as warranty costs ease; revenue dips 16%

electrode technologies · margin expansion · warranty cost normalization

ResultsQ1 FY273 minIndustrials & Infra
AWLAdani Wilmar Ltd

AWL Agri Q1: consolidated PAT jumps 48% YoY to ₹351 Cr as edible-oil margins expand

edible oil · fmcg · margin expansion

ResultsQ1 FY273 minFMCG
OALOriental Aromatics Ltd-$

Oriental Aromatics: consol PBT more than doubles YoY to ₹5.27 Cr; subsidiary losses cap PAT

fine chemicals · aroma chemicals · margin compression

ResultsQ1 FY273 minMetals & Mining
TORNTPHARMTORRENT PHARMACEUTICALS LTD.

Torrent Pharma revenue +55% on JB merger; consolidated PAT flat at ₹566 Cr as net margin compresses

pharma · jb pharma merger · acquisition-led growth

ResultsQ1 FY273 minPharma & Healthcare
RAINBOWRainbow Children's Medicare Ltd

Rainbow Q1: consolidated revenue +33% YoY to ₹470 Cr; PAT +16% as margins compress on expansion

hospitals · healthcare · revenue growth

ResultsQ1 FY273 minPharma & Healthcare
PAUSHAKLTDPAUSHAK LTD.

Paushak Q1: revenue leaps ~50% YoY to ₹83.6 Cr, PAT +25% to ₹15.1 Cr as margins slip

specialty chemicals · phosgene · revenue growth

ResultsQ1 FY273 minMetals & Mining
NUCLEUSNUCLEUS SOFTWARE EXPORTS LTD.

Nucleus Q1 PAT falls 32% YoY to ₹23.9 Cr — far worse ex a ₹9.8 Cr one-off; margins squeezed

banking software · lending software · margin compression

ResultsQ1 FY273 minTechnology / IT
SATINSatin Creditcare Network Ltd

Satin Creditcare Q1 FY27: consol PAT triples YoY to ₹122.6 Cr, beats Street view

microfinance · nbfc · aum growth

ResultsQ1 FY273 minFinancial Services
THERMAXTHERMAX LTD.

Thermax Q1: consolidated PAT crashes 86% to ₹22 Cr on ₹91 Cr project cost overrun

capital goods · energy transition · cost overrun

ResultsQ1 FY273 minIndustrials & Infra
NIVABUPANiva Bupa Health Insurance Company Ltd

Niva Bupa Q1: PAT ₹138 Cr, near-doubles YoY on Ind AS basis; combined ratio to 93.6%

health insurance · ind as 117 · combined ratio

ResultsQ1 FY273 minFinancial Services
SWIGGYSwiggy Ltd

Swiggy Q1: consolidated loss narrows to ₹791 Cr as revenue climbs 37% YoY

food delivery · quick commerce · instamart

ResultsQ1 FY273 minConsumer & Retail
EBGNGGNG Electronics Ltd

GNG Electronics Q1: consolidated PAT +56% YoY to ₹29 Cr, margins expand as revenue jumps 32%

refurbished electronics · ict devices · margin expansion

ResultsQ1 FY273 minTechnology / IT
MEDANTAGlobal Health Ltd

Medanta Q1: revenue +26% YoY, consolidated PAT flat at Rs157 Cr as Noida ramp squeezes margins

hospitals · healthcare services · revenue growth

ResultsQ1 FY273 minPharma & Healthcare
VEDLVedanta Limited

Vedanta Q1 FY27: continuing-ops PAT jumps 152% YoY to ₹5,294 Cr as Zinc-Silver margins hit 30%

zinc silver · margin expansion · demerger

ResultsQ1 FY273 minMetals & Mining
HYUNDAIHyundai Motor India Ltd

Hyundai Q1 profit drops 35% YoY to ₹889 Cr on margin squeeze; revenue flat at ₹16,335 Cr

passenger vehicles · auto sector · margin compression

ResultsQ1 FY273 minAutomobile
MANKINDMankind Pharma Ltd

Mankind Pharma Q1: consolidated PAT up 29% YoY to ₹574 Cr on EBITDA margin expansion

pharma · domestic formulations · margin expansion

ResultsQ1 FY273 minPharma & Healthcare